Depression decisions — 2025

The Board granted the Veteran's claim for eligibility to the direct payment of attorney fees from past-due benefits awarded in a May 2022 rating decision.

The Board granted a 30 percent rating for migraine headaches prior to March 9, 2023, and denied a higher rating as of that date. The Board also granted a 70 percent rating for major depressive disorder with anxious distress.

The Board denied service connection for PTSD and remanded claims for service connection for an acquired psychiatric disorder, left lower nerve pain, right lower nerve pain, bilateral pes planus, and tinnitus.

The appeal for service connection for a depressive disorder was dismissed as untimely, while the appeal for sleep apnea is remanded due to an inadequate VA examination.

The appeal of the issues related to increased disability evaluations for various conditions, including peripheral vestibular disease, anxiety disorder with depressive disorder and insomnia disorder, left ear hearing loss, bilateral hearing loss, and tinnitus were dismissed due to procedural defects.

The Board remands the claims for service connection for an acquired psychiatric disability and a right ankle disability for readjudication as new and relevant evidence has been received.

The Board remands the claims for service connection for a back condition, depression, anxiety, and insomnia as well as an increased rating claim for service-connected bilateral hearing loss and for an allowance for an automobile or other conveyance, and adaptive equipment, or adaptive equipment only due to pre-decisional duty-to-assist errors.

The Board denied service connection for chronic fatigue syndrome and traumatic brain injury, but remanded several other claims related to the character of discharge and various medical conditions.

The appeal for a 10 percent disability rating based on multiple noncompensable service-connected disabilities is dismissed as the Veteran has been in receipt of a compensable disability rating throughout the period on appeal.

The Board remands the claim for an acquired psychiatric disorder, to include depression and major depressive disorder, for a direct service connection opinion.

The Board remands the claim for a new VA opinion to address whether the Veteran's major depressive disorder (MDD) is related to his service-connected disabilities on a secondary basis.

The Board remands the claims for further development to correct duty to assist errors.

The Board granted service connection for tinnitus and awarded a TDIU, while denying increased ratings for bilateral hearing loss, benign prostate hypertrophy, persistent depressive disorder with anxious distress, scars, and sleep apnea.

The Board granted service connection for a left ankle disability, obstructive sleep apnea secondary to allergic rhinitis, and irritable bowel syndrome. A 70 percent rating was also granted for major depressive disorder.

The appeal for service connection for depression was granted, while the claims for service connection for various other disabilities were denied.

The Board granted service connection for migraine disability, which is linked to the Veteran's service-connected tinnitus. Other claims for allergic rhinitis, unspecified anxiety, depression, and insomnia, and sinusitis were denied.

The Board granted service connection for an acquired psychiatric disorder, to include major depressive disorder recurrent moderate with anxious distress, as secondary to the Veteran's service-connected left shoulder degenerative arthritis.

The Board granted a 10 percent evaluation for varicose veins of the left leg with scar prior to December 16, 2024, and denied an evaluation in excess of 10 percent. Other claims were either denied or remanded.

The Board granted an effective date of September 27, 1985 for the grant of service connection for major depressive disorder based on new and relevant service department records that were not previously associated with the claim file.

The Board granted service connection for an acquired psychiatric disorder, to include PTSD and major depressive disorder with anxious distress and cannabis use disorder.